Guangzhou Innogen Pharmaceutical Group Co Ltd Class H (HK:2591)
:2591
Want to see HK:2591 full AI Analyst Report?
Comparison Results
Guangzhou Innogen Pharmaceutical Group Co Ltd Class H
HK$30.42
HK$6.40B
-35.93
-75.23%
1 Buy
0 Hold
0 Sell
Moderate Buy
Alphamab Oncology
HK$11.90
HK$10.04B
-76.25
28.03%
1 Buy
0 Hold
0 Sell
Moderate Buy
RemeGen Co. Ltd. Class H
HK$119.90
HK$73.23B
36.25
137.08%
6 Buy
0 Hold
0 Sell
Strong Buy
Jacobio Pharmaceuticals Group Co., Ltd.
HK$8.06
HK$5.51B
-31.16
70.15%
2 Buy
0 Hold
0 Sell
Moderate Buy
CARsgen Therapeutics Holdings Ltd.
HK$14.89
HK$12.49B
-77.24
34.76%
1 Buy
0 Hold
0 Sell
Moderate Buy
Ascentage Pharma Group International
HK$50.90
HK$16.54B
-13.81
-10.86%
2 Buy
0 Hold
0 Sell
Moderate Buy
Performance Comparison
HK:2591
Guangzhou Innogen Pharmaceutical Group Co Ltd Class H
14.18
-38.42
-73.04%
HK:9966
Alphamab Oncology
10.05
2.02
25.16%
HK:9995
RemeGen Co. Ltd. Class H
98.15
56.75
137.08%
HK:1167
Jacobio Pharmaceuticals Group Co., Ltd.
6.84
2.97
76.74%
HK:2171
CARsgen Therapeutics Holdings Ltd.
21.48
5.54
34.76%
HK:6855
Ascentage Pharma Group International
43.32
-7.08
-14.05%